Literature DB >> 22586265

Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses.

Barbara Kroczynska1, Bhumika Sharma, Elizabeth A Eklund, Eleanor N Fish, Leonidas C Platanias.   

Abstract

The precise mechanisms by which the activation of interferon (IFN) receptors (IFNRs) ultimately controls mRNA translation of specific target genes to induce IFN-dependent biological responses remain ill defined. We provide evidence that IFN-α induces phosphorylation of programmed cell death 4 (PDCD4) protein on Ser67. This IFN-α-dependent phosphorylation is mediated by either the p70 S6 kinase (S6K) or the p90 ribosomal protein S6K (RSK) in a cell-type-specific manner. IFN-dependent phosphorylation of PDCD4 results in downregulation of PDCD4 protein levels as the phosphorylated form of PDCD4 interacts with the ubiquitin ligase β-TRCP (β-transducin repeat-containing protein) and undergoes degradation. This process facilitates IFN-induced eukaryotic translation initiation factor 4A (eIF4A) activity and binding to translation initiation factor eIF4G to promote mRNA translation. Our data establish that PDCD4 degradation ultimately facilitates expression of several ISG protein products that play important roles in the generation of IFN responses, including IFN-stimulated gene 15 (ISG15), p21(WAF1/CIP1), and Schlafen 5 (SLFN5). Moreover, engagement of the RSK/PDCD4 pathway by the type I IFNR is required for the suppressive effects of IFN-α on normal CD34(+) hematopoietic precursors and for antileukemic effects in vitro. Altogether, these findings provide evidence for a unique function of PDCD4 in the type I IFN system and indicate a key regulatory role for this protein in mRNA translation of ISGs and control of IFN responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22586265      PMCID: PMC3416205          DOI: 10.1128/MCB.00310-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4.

Authors:  Anja Hilliard; Brendan Hilliard; Shi-Jun Zheng; Honghong Sun; Takashi Miwa; Wenchao Song; Rüdiger Göke; Youhai H Chen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Type I interferon prolongs cell cycle progression via p21WAF1/CIP1 induction in human colon cancer cells.

Authors:  Tomonari Katayama; Kazuaki Nakanishi; Hiroshi Nishihara; Naoya Kamiyama; Takahito Nakagawa; Toshiya Kamiyama; Ken Iseki; Shinya Tanaka; Satoru Todo
Journal:  Int J Oncol       Date:  2007-09       Impact factor: 5.650

Review 3.  JAK-STAT signaling: from interferons to cytokines.

Authors:  Christian Schindler; David E Levy; Thomas Decker
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

4.  Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling.

Authors:  Surinder Kaur; Antonella Sassano; Ajith M Joseph; Beata Majchrzak-Kita; Elizabeth A Eklund; Amit Verma; Saskia M Brachmann; Eleanor N Fish; Leonidas C Platanias
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions.

Authors:  Sachiko Matsuhashi; Yutaka Narisawa; Iwata Ozaki; Toshihiko Mizuta
Journal:  Exp Dermatol       Date:  2007-03       Impact factor: 3.960

6.  siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression.

Authors:  N Bitomsky; N Wethkamp; R Marikkannu; K-H Klempnauer
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

7.  SMAD proteins control DROSHA-mediated microRNA maturation.

Authors:  Brandi N Davis; Aaron C Hilyard; Giorgio Lagna; Akiko Hata
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

Review 8.  Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.

Authors:  R Zivadinov; A T Reder; M Filippi; A Minagar; O Stüve; H Lassmann; M K Racke; M G Dwyer; E M Frohman; O Khan
Journal:  Neurology       Date:  2008-07-08       Impact factor: 9.910

9.  Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.

Authors:  Giridhar Mudduluru; Fabian Medved; Rainer Grobholz; Camela Jost; Anette Gruber; Joerg H Leupold; Stefan Post; Aaron Jansen; Nancy H Colburn; Heike Allgayer
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more
  17 in total

1.  Interferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses.

Authors:  Barbara Kroczynska; Robert L Rafidi; Beata Majchrzak-Kita; Ewa M Kosciuczuk; Gavin T Blyth; Jacek Jemielity; Zofia Warminska; Diana Saleiro; Swarna Mehrotra; Ahmet Dirim Arslan; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

2.  Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs.

Authors:  Shuo Wang; Christos Patsis; Antonis E Koromilas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.

Authors:  Swarna Mehrotra; Bhumika Sharma; Sonali Joshi; Barbara Kroczynska; Beata Majchrzak; Brady L Stein; Brandon McMahon; Jessica K Altman; Jonathan D Licht; Darren P Baker; Elizabeth A Eklund; Amittha Wickrema; Amit Verma; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

4.  KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.

Authors:  Jamie L McCall; Drew Gehring; Beth K Clymer; Kurt W Fisher; Binita Das; David L Kelly; Hyunseok Kim; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

5.  Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses.

Authors:  Surinder Kaur; Barbara Kroczynska; Bhumika Sharma; Antonella Sassano; Ahmet Dirim Arslan; Beata Majchrzak-Kita; Brady L Stein; Brandon McMahon; Jessica K Altman; Bing Su; Raffaele A Calogero; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

6.  Central role of ULK1 in type I interferon signaling.

Authors:  Diana Saleiro; Swarna Mehrotra; Barbara Kroczynska; Elspeth M Beauchamp; Pawel Lisowski; Beata Majchrzak-Kita; Tushar D Bhagat; Brady L Stein; Brandon McMahon; Jessica K Altman; Ewa M Kosciuczuk; Darren P Baker; Chunfa Jie; Nadereh Jafari; Craig B Thompson; Ross L Levine; Eleanor N Fish; Amit K Verma; Leonidas C Platanias
Journal:  Cell Rep       Date:  2015-04-16       Impact factor: 9.423

7.  Regulatory effects of SKAR in interferon α signaling and its role in the generation of type I IFN responses.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Beata Majchrzak-Kita; Ahmet Dirim Arslan; Jessica K Altman; Brady L Stein; Brandon McMahon; Piotr Kozlowski; Philipp J Kahle; Elizabeth A Eklund; Eleanor N Fish; Leonidas C Platanias
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

Review 8.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

Review 9.  Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.

Authors:  Eleanor N Fish; Leonidas C Platanias
Journal:  Mol Cancer Res       Date:  2014-09-12       Impact factor: 5.852

10.  Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors.

Authors:  Jessica K Altman; Amy Szilard; Bruce W Konicek; Philip W Iversen; Barbara Kroczynska; Heather Glaser; Antonella Sassano; Eliza Vakana; Jeremy R Graff; Leonidas C Platanias
Journal:  Blood       Date:  2013-03-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.